Ataga, Kenneth I. http://orcid.org/0000-0002-4501-9982
Saraf, Santosh L. http://orcid.org/0000-0002-8584-4194
Derebail, Vimal K. http://orcid.org/0000-0002-7662-7497
Article History
Accepted: 19 January 2022
First Online: 21 February 2022
Competing interests
: K.I.A. has received research funding from Novartis and Global Blood Therapeutics, served on advisory boards for Novartis, Global Blood Therapeutics, Novo Nordisk, Editas Medicine, Forma Therapeutics and Agios Pharmaceuticals, and as a consultant for Roche. S.L.S. receives research funding support from Novartis, Pfizer and Global Blood Therapeutics, and served on advisory boards for Novartis and Global Blood Therapeutics. V.K.D. has served on advisory boards for Novartis, Bayer and Travere.